View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
VA | RIN: 2900-AQ31 | Publication ID: Fall 2018 |
Title: Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists | |
Abstract:
The Department of Veterans Affairs (VA) is amending its medical regulations that govern copayments to conform with recent statutory requirements. VA is eliminating the copayment requirement for veterans who are at high risk for overdose or a specific medication or substance in order to reverse the effect of such an overdose. VA is also clarifying that no copayment will be required for the provision of education on the use of opioid antagonists. |
|
Agency: Department of Veterans Affairs(VA) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: No | Unfunded Mandates: No |
EO 13771 Designation: Other | |
CFR Citation: 38 CFR 17.108 38 CFR 17.110 | |
Legal Authority: Pub. L. 114-198, sec. 915 Pub. L. 114-223, sec. 243 38 U.S.C. 1701 38 U.S.C. 1722A(a) |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Sandra Mize Program Analyst (CBO FO) Department of Veterans Affairs 3773 Cherry Creek North Drive, Denver, CO 80209 Phone:303 331-7545 Email: sandra.mize@va.gov |